Mouthrinses against SARS-CoV-2: anti-inflammatory effectivity and a clinical pilot study.

Matthias SchürmannMohamed AljubehCarsten TiemannHolger Sudhoff

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2021)

We recommend the application of mouth wash solutions to COVID-19 patients, since our results indicate a reduction in infectivity and might govern the protection of health care professionals. Further improvement to the over the counter formulation can be made by utilizing zinc and dexpanthenol, as they which might be beneficial for the patients' health.

Keyphrases

sars cov
healthcare
end stage renal disease
anti inflammatory
ejection fraction
public health
chronic kidney disease
newly diagnosed
mental health
prognostic factors
peritoneal dialysis
drug delivery